Inhibition of IL11, by a variety of means, is associated with reduced cancer initiation, progression and metastasis and IL11 is being explored as a therapeutic target in combination with immunotherapy for some human cancers by Mabwell Therapeutics (below). This evidence concerns the gene IL11 and cancer.